BioScript - Newfoundland and Labrador Non-Medical Switch Announcement

Home > Newfoundland and Labrador Non-Medical Switch Announcement - Private Coverage

Dear Patient,

Please note that the province of Newfoundland and Labrador has decided to move forward with a non-medical switch strategy. A non-medical switch is a provincial initiative that transitions Newfoundland and Labrador Prescription Drug Program (NLPDP) coverage from the brand name to the biosimilar version of the drug.

As a result, provincial public coverage of Humira, Enbrel, Rituxan, Remicade, and Copaxone is changing and will no longer be covered under the NLPDP as of April 1, 2024. Affected patients will need to be switched to a biosimilar to continue therapy.

As a patient who is privately insured, you are unaffected by this initiative at this time. If there are anticipated changes to your coverage, please contact the BioScript Pharmacy team immediately for support at 709-579-0528 or nl@bioscript.ca.

All patients can remain with BioScript Pharmacy and Coverdale Clinics with no changes in their access to care, as BioScript Pharmacy services all biosimilars. Transferring to another pharmacy is not required and may result in changes to delivery arrangements, clinic access, and pharmacy care.

Thank you for allowing us to be a part of your medical treatment, and we look forward to continuing as your pharmacy provider of choice.

For any questions, please contact us at 709-579-0528 or nl@bioscript.ca.

Your BioScript Pharmacy Team